Atlas FDA

IBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment of patients wi

FDA device recall Z-1945-2024 · posted 2024-06-03 · Open, Classified

Recall details

Recalling firm
Ion Beam Applications S.A.
Reason for recall
Irradiation is not interrupted when some C230 Accelerator Control Unit critical parameters are outside of the defined tolerances
Action taken
Iba issued Urgent Medical Device Correction Letter on May 10, 2024 via IBA responsible directly to customer site either by hand or by email. Letter states reason for recall, health risk and action to take: ACTION BEING TAKEN BY IBA Monitoring of the deflector, software upgrade. 7.2 CORRECTIVE ACTIONS Software upgrade 7.3 PREVENTIVE ACTIONS Waiting for the solution to be deployed, IBA will distribute an Internal User Notice to IBA operators of impacted sites with instructions to monitor the deflector and stop the irradiation when necessary. 7.4 TIME SCHEDULE FOR THE IMPLEMENTATION OF THE DIFFERENT ACTIONS The Internal User Notice will be provided to IBA operators by May 10, 2024. The corrective action will be implemented at your site by June 2025. Contact: Sonia PINEL Vigilance@iba-group.com
Root cause
Device Design
Status
Open, Classified
Product code
LHN
Quantity affected
2 units
Distribution
Worldwide - US Nationwide distribution in the state of Virginia and the country of India.
Date initiated
2024-05-10
Date posted
2024-06-03
Location
Ottignies-Louvain-La-Neuve, Belgium

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
IBA Proton Therapy System- Proteus 235 (Proteus One, Proteus Plus, Proteus TK2, Proteus Class) (K163500)Ion Beam Applications S.A.2017-08-17